Picard Medical Seeks Votes on $5M Private Placement and Expanded Equity Plan
PMI has more than doubled off its 52-week low of $2.652 on light trading volume (0.1× avg).
Summary
Picard Medical scheduled a December 7, 2026 special meeting to approve a $5 million private placement of up to 1,666,666 shares at a $3.00 floor and a restated equity incentive plan reserving 532,315 shares. The placement also hands investors a board nominee and a veto over future equity financings.
Key Events · Financing and Capital Events · PMI
-
Special Meeting Set for December 7
Stockholders of record on November 6, 2026 vote on the private placement, the restated equity plan and an adjournment proposal; the board recommends FOR each.
-
$5M Placement at $3.00 Floor
Up to 1,666,666 shares for an aggregate $5,000,000, with the per-share price floored at $3.00 — well below the $7.48 last sale — and no shares issued until the full amount is received.
-
Investor Consent Right Over Financings
While the Investor Group holds its ownership threshold and seats an Investor Director, the company cannot issue equity or convertible securities in a financing without that director's consent; equity plan issuances are excluded.
-
Equity Plan Reserve Grows to 532,315
The restated plan adds 172,315 shares reserved exclusively for Program Awards on top of 360,000 legacy shares, with an evergreen of up to 5% of shares outstanding annually from 2027 through 2035.
Analysis · PMI · Industrial Applications And Services
A $5 million private placement is roughly a quarter of this company's market value, and it is priced with a $3.00 floor against a $7.48 last sale — the company is pre-committing to sell at a steep discount to today's price if that is what it takes to get the money in. The cash arrives in two pieces: an advance within five business days of signing, with the balance only after stockholders approve at the December 7 special meeting. In exchange, the investors get a board seat nomination right and, more importantly, a consent right over any future equity or convertible financing while they hold their stake — that constrains how else the company can raise money. The same ballot asks for a restated equity plan with 532,315 shares reserved (360,000 legacy plus a 172,315 program reserve) and an evergreen of up to 5% of shares outstanding each year through 2035, which is a second, slower form of dilution layered on top of the placement.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PMI was trading at $7.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.1M. The 52-week trading range was $2.65 to $684.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.